Compare with Organon & Co. 7.875% 15-MAY-2034
Key terms
Profile
Sector
Health Technology
Industry
Pharmaceuticals: Major
Home page
ISIN
USU6836GAB42
CUSIP
U6836GAB4
FIGI
BBG01MRS6KV4
Identifiers
ISIN USU6836GAB42
Organon & Co. is a science based global pharmaceutical company, which develops and delivers innovative health solutions through a portfolio of prescription therapies within women’s health, biosimilars and established brands. The company was founded on March 11, 2020, and is headquartered in Jersey City, NJ.
Sign up to see advanced bond data
Unlock important bond data including coupon rates, redemption details, risk assessments, and much more.